FRIDAY, Dec. 6, 2024 (HealthDay News) — There’s new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers report. An experimental new drug with the unwieldy name of cretostimogene grenadenorepvec spurred complete remission of the cancer in three-quarters of patients who hadn’t responded toContinue Reading

TUESDAY, Dec. 3, 2024 (HealthDay News) — A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show. Aucatzyl (obecabtagene autoleucel) worked on more than three-quarters (76%) of patients with B-cell acute lymphoblastic leukemia (ALL), and more than half (55%) went into remission, accordingContinue Reading

MONDAY, Dec. 2, 2024 (HealthDay News) — A new study provides good evidence that the human papillomavirus (HPV) vaccine may be achieving its goal of slashing rates of cervical cancer. “We observed a … 62% drop in cervical cancer deaths over the last decade, likely due to HPV vaccination,” saidContinue Reading